Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Malignant Neoplasm
51%
Nanoparticle
40%
Chemotherapy
29%
Pharmacokinetic
29%
Tumor Growth
22%
Combination Therapy
13%
Solid Malignant Neoplasm
13%
microRNA 155
12%
Immunotherapy
11%
Diseases
11%
Nanomedicine
11%
Nanomaterial
11%
Vascular Tumor
10%
Breast Cancer
10%
Immune Checkpoint Inhibitor
10%
Drug Resistance
10%
SARS Coronavirus
9%
Nanocarrier
9%
Infection
9%
COVID-19 Vaccine
9%
Doxorubicin
8%
Biological Marker
8%
Non Small Cell Lung Cancer
7%
Drug Transport
7%
Drug Delivery System
7%
Bacteriophage
6%
Epitope
6%
Lung Cancer
6%
Colorectal Carcinoma
6%
Pharmacodynamics
5%
Medicine and Dentistry
Neoplasm
63%
Malignant Neoplasm
33%
Oncology
23%
Immunotherapy
20%
Tumor Progression
16%
Breast Cancer
15%
Biological Marker
12%
Intraductal Carcinoma
12%
Diseases
12%
Solid Malignant Neoplasm
10%
Pancreas Cancer
10%
Cancer Cell
9%
Cancer Immunotherapy
9%
Pancreas Adenocarcinoma
9%
Computer Assisted Tomography
9%
Vascular Tissue Neoplasm
7%
Treatment Response
7%
Tumor Invasion
6%
Nanoparticle
6%
Histopathology
6%
Epitope
6%
Triple Negative Breast Cancer
6%
Phage Display
6%
Cancer Growth
6%
In Vitro
5%
Mammography
5%
Cancer Therapy
5%
Radiation Therapy
5%
Keyphrases
Mathematical Modeling
17%
Nanoparticles
13%
Tumor
12%
Mechanistic Modeling
12%
Tumor Response
10%
MicroRNA-155 (miR-155)
9%
Cancer Immunotherapy
9%
Pharmacokinetics
9%
Clinical Translation
8%
Immune Response
7%
Tumor Delivery
7%
Nanomaterials
7%
Mathematical Model
6%
Mechanistic Model
6%
Elliott Wave Principle
6%
Anti-microRNA
6%
Mathematical Modeling of Cancer
6%
Lung Cancer
6%
Tumor Burden
6%
Ductal Carcinoma in Situ
6%
Combination of Therapies
6%
Models of Radiation Responses
6%
Response Calibration
6%
Dissolvable Microneedles
6%
Aging Effect
6%
Physiological Changes
6%
COVID-19 Vaccine
6%
In Cancer
5%
Immune Checkpoint Inhibitors
5%
